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Summary. Lytic transition of Epstein-Barr virus (EBV) is initiated by distinct 
immediate arly regulators of the viral cycle, in synchronization to temporary, 
permissive conditions during host cell differentiation. We developed eukaryotic 
vectors uitable to imitate the processes involved in lyric transition in cell culture 
systems. Two stable B cell lines were established: R59Z activator cells were 
used to induce lytic EBV expression i  a constitutive manner by the production 
of the BZLF 1 trans-activator (Zta). R7-57 reporter cells, on the other hand, 
signaled induced activity of the lyric origin of EBV replication (ori Lyt). Different 
modes, like chemical induction, lyric superinfection with EBV and single gene 
trans-activation converted the recombinant ori Lyt element in R7-57 reporter 
cells. BZLF 1, transiently expressed in R7-57 reporter cells, was the only EBV 
trans-activator found, sufficient in inducing the viral lytic cycle. Basing on these 
experiments, trans-cellular activation of EBV was tested by cocultivation of 
BZLF 1-expressing R59Z activator cells with the R7-57 reporter line. No lyric 
effect on the reporter cells could be measured, neither by cocultivation of 
activator cells nor by coincubation of BZLF 1-containing cell lysates. Latency 
breaking activity, however, was transferred from activator to reporter cells when 
active, exogenous virus was added. The cell system described in these experi- 
ments provides a tool for the detection of EBV reactivation and demonstrates 
the potential of the lytic regulatory gene BZLF 1. 
Introduction 
The regulation of the replicative cycle in Epstein-Barr virus (EBV) infection, 
i.e., establishment of latency or initiation of the lytic cascade, is subject to 
complex interactions between viral and cellular genes and gene products. In 
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vivo, the spread of EBV is coordinated with the lytic activity in two cell pools: 
B-lymphocytes tend to maintain latent EBV genomes, whereas certain epithelial 
cells favour the switch to lytic reproduction. Various in vitro experiments sug- 
gested an interlocking of cellular and viral processes in gene activation. External 
stimuli on the host cell [16, 29, 31] were shown to initiate the expression of 
viral immediate arly trans-activators, e.g. BZLF 1 (Barn HI Z left frame 1) [-3, 
9]. As a consequence products of the early lytic gene cascade are started being 
expressed and convert he EBV genome from the latent to the lytic state [5, 
6]. As a secondary function, the viral trans-activators possibly feed back to 
regulation of the host cell [28]. 
Experimental ctivation of EBV, as described in the culture systems below, 
gives insight he viral response to cellular changes. The resident, mutated EBV 
genome of Raji cells, which is maintained in the latent phase over long periods, 
can be induced to express the viral immediate arly and early cascade [ 11, 16]. 
Our Raji test system was based on the activity of the ori Lyt regulatory element. 
Ori Lyt was characterized as a bifunctional element, acting as origin of DNA 
replication [-10] as well as a divergent promoter complex [7]. Both functions 
remain silenced during latency and are induced with the lytic switch of the 
genome. Transcriptional ctivation of recombinant ori Lyt was utilized to drive 
a reporter construct in Raji cells underlying inducing culture conditions. 
BZLF 1 plays the key role in the transmission of inducing signals from the 
host cell towards the replicative activation of the viral genome [15, 17, 26]. 
Besides up-regulation of viral regulatory genes in a cascade-like manner, direct 
trans-activation f oriLyt by the BZLF 1 product was reported [7, 13]. In 
different cell types the xpression of BZLF 1 appeared immediately linked to 
virus production, indicating its essential role in the lytic cycle. Detailed analysis 
of EBV antigens in tissues of oral hairy leukoplakia (OHL) revealed abundant 
BZLF 1 production in immature, differentiating cells[2]. In these OHL layers, 
virus multiplication was obviously suppressed, but characteristic lesions of 
neighbouring cells, termed koilocytosis, were repeatedly described [2, 19, 33]. 
EBV immediate arly gene expression seems to lead, directly or indirectly, to 
a signal which influences tissue cells in nearest proximity. Furthermore it is an 
open question whether the BZLF 1 trans-activator can spread the lytic transition 
of EBV in a trans-cellular manner, as reported for other viral regulatory proteins, 
e.g., HIV Tat [14]. 
Materials and methods 
Construction feukaryotic vectors 
Plasmids were constructed with the ability to persist in eukaryotic cells in a episomal 
form, based on the elements of EBV replication [21, 32], i.e., plasmid p220.2 (supplied 
by Bill Sugden, McArdle Laboratory, University of Wisconsin, Madison, U.S.A.). The 
specific DNA sequences were introduced into the polylinker of p 220.2, using restriction 
sites Barn HI/Hin d III (pEBV 57) and Barn HI/Sal I (pEBV 59), respectively. Subcloning of 
the original viral sequences was described elsewhere: HBsAg coding sequence [22], BZLF 1 
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coding sequence [23] and CMV immediate arly promoter-enhancer [4]. The ori Lyt reg- 
ulatory element was subcloned as a 1060 bp fragment from the EBV Barn HI H clone [1, 
30] using Hin cII and Apa LI restriction sites. 
Selection of recombinant cells 
Raji cells (Burkitt's lymphoma) were transfected by the DEAE dextran technique [24-] with 
simple modifications [22]. Positive clones were selected for hygromycin B resistance, en- 
coded by pEBV 57 and pEBV 59. Two days posttransfection the cells were exposed to 
increasing concentrations of hygromycin B. At each change of medium 50 to 200 gg/ml 
were added. Resistant cells were centrifuged in Ficoll gradients (density 1,077) to remove 
cell debris. The selection was repeated until the culture remained unimpaired uring an- 
tibiotic treatment. 
Virus strains 
P3HR-1 cells (Burkitt's lymphoma) and B 95-8 cells (marmoset lymphocytes, in vitro con- 
verted with EBV) were used as EBV producer lines. The cultures were grown in RPMI 1640 
medium with 10% heat-inactivated foetal calf serum, 100 units/ml of penicillin and 250 gg/ 
ml of streptomycin, at 37 °C. Virus production was induced chemically by treatment with 
40 nM of TPA and 3 mM of butyric acid with an additional stimulatory temperature shift 
to 32 °C and serum reduction to 5% for 10 days. Virus tocks were prepared by ultracen- 
trifugation of the supernatant a 20,000 x g for 2 h. See legends of Figs. 3 and 4 for details 
of infection experiments. 
In situ hybridization 
In situ hybridization was used to detect ransfected DNA in lymphocytes. Stationary resting 
cells were rinsed in phosphate-buffered saline (PBS), spotted onto degreased microscope 
slides and fixed in 4% paraformaldehyde, 7.2mg/ml of NaC1, 0.43 mg/ml of KH2PO4, 
t.5 mg/ml of Na2HPO4, pH 7.3 for 2.5 min at room temperature. Slide preparations were 
rinsed in PBS and treated with proteinase K (1 gg/ml in 10 mM Tris / 1 mM EDTA, pH 7.4) 
for 15min at 37oc. Following a second fixation step for 30min, the cell areas were pre- 
hybridized with hybridization mixture (6 x SSC, 5 x Denhardt's reagent, 45% formamide) 
containing 100gg/ml of denatured salmon sperm DNA for 15min at 42°C [27]. After 
careful removal of the prehybridization mixture, 30 ng of digoxigenin-labeled probe DNA 
(denatured at 90°C for 10 min) per 30 gl of hybridization mixture were placed on each spot 
of cells (denatured for 5 min on a heating block before rapidly put on ice). For probe 
specificity see legend of Fig. 2. Coverslips were mounted, sealed with rubber cement and 
hybridization was carried out in a humid chamber at 42 °C overnight. The subsequent 
immunological colour detection was performed according to the standard protocol by 
Boehringer Mannheim (nonradioactive DNA labeling and detection kit). 
Immunofhtorescence and Western blot 
For indirect immunofluorescence, transfected cells were fixed in ice-cold acetone for 5 min. 
Human antisera and secondary fiuorescein isothiocyanate-linked goat anti-human anti- 
bodies (Medac) were applied each at a dilution of 1 : 50 for 1 h at 37 °C. Each incubation 
was stopped by rinsing twice with ice-cold PBS for 15 min. The slides were analyzed under 
the microscope at  magnification of 250. For Western blots, the applied standard im- 
munotechniques and staining procedures were described previously [23]. 
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Radioimmunoassay nd enzyme-linked immunoassay 
Radioimmunoassay was used to quantitate the activity of promoter elements, as described 
for the HBsAg (hepatitis B virus surface antigen) reporter system [22]. In brief, recombinant 
HBsAg, used as reporter protein, was secreted from transfected cells. HBsAg production 
was assayed in supernatant aliquots by the commercially available radioimmunoassay 
(Abbott). Since cell lysis was not required, transfection assays could be monitored contin- 
uously over a period of time. 
The nonradioactive quantitation of reporter protein was performed by an enzyme- 
linked immunoassay (Abbott) using peroxidase-conjugated, s condary antibodies. The per- 
oxidase substrate was incubated for 30 rain in the dark before the optical density at 492 nm 
was determined. 
Results 
The establishment of recombinant cell systems allows the analysis of mechanisms 
involved in EBV reactivation by indirect, quantitative methods. Two episomal 
constructions, as shown in Fig. 1, were stably introduced into cell culture: 
pEBV 57 was based on the artificial linkage of the EBV ori Lyt element, upstream 
to the HBsAg coding sequence. Transcriptional activity ofori Lyt was monitored 
by HBsAg reporter expression [22]. pEBV 59 encoded the EBV BZLF 1 trans- 
activator (Zta) under constitutive control of the CMV immediate early pro- 
moter-enhancer. BZLF 1 expression was analyzed in its capability to induce the 
EBV lytic cycle in B-lymphocytes. Raji cells were chosen as targets, because of 
their permanent latent infection with a mutated, nonproductive EBV strain 
[11]. 
Hygromycin B-resistant cell clones (R7-57 and R59Z), each carrying one of 
the episomal constructions (pEBV 57 and pEBV 59) were selected. The stability 
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Fig. 1. Eukaryotic vectors elected in recombinant cells. The vectors used in these experi- 
ments were based on three sets of modules: (i) Origins of DNA replication for eukaryotic 
(EBV ori P in cis and EBNA-1 in trans) [32] and prokaryotic cells (colE1 ori), (ii) antibiotic 
selection markers for eukaryotic (hygromycin B) and prokaryotic cells (ampicillin) and (iii) 
inserted test genes (ori Lyt element::HBsAg reporter or CMV promoter-enhancer::BZLF 1 
trans-activator, respectively). The vectors pEBV 57 and pEBV 59, drawn in their linear 
organization, are maintained in the cell in a circular form. EBNA Epstein-Barr virus nuclear 
antigen; ori origin of replication; HBsAg hepatitis B virus surface antigen; CMV cyto- 
megalovirus; BZLF1 Barn HI Z left frame 1 
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Fig. 2. Recombinant Raji cells (R7-57-pEBV 57 and R59Z-pEBV 59) replicating and ex- 
pressing eukaryotic vectors. A In situ hybridization was performed with Raji (1) and R7- 
57 cells (2) screening for pEBV 57. A 900 bp Bam HI fragment of the HBsAg sequence 
which was labeled with digoxigenin was used as hybridization probe. Representative positive 
signals from three independent, parallel assays are shown in 2. Using human antisera of 
HBV-positive donors, immunofluorescence analysis of HBsAg was performed in latent R7- 
57 cells (3) and after lyric superinfection with P3HR-1 virus for 2 days (4, positive signals 
from three parallel assays). For details of superinfection see l gend of Fig. 3. B Western 
blotting of cell extracts assayed for BZLF 1 protein using a monospecific rabbit antiserum: 
1 Raji, 2 Raji superinfected with P3HR-1 virus, 3 R59Z before selection, 4 R59Z after 
selection. Note the strain-specific size variation between superinfecting P3HR-1 type and 
recombinant B 95-8 type BZLF 1 [5] 
of the recombinant DNA was demonstrated by in situ hybridization. As shown 
in Fig. 2 A, panel 2, typically large, blast-like cells gave strong, positive hybrid- 
ization signals after antibiotic selection. Full functional integrity of the inserted 
test genes was analyzed by detection of their protein expression. The ori Lyt 
element remained in its inducible form (Fig. 2A, panel4), while the BZLF 1 
protein was expressed in a constitutive way (Fig. 2 B). 
R7-57 cells served as a stable reporter line for the lytic transition of the viral 
genome (Fig. 3). Untreated cells stayed exclusively in the latent phase. Accord- 
ingly the reporter level remained at a very low background. Chemical induction 
with TPA led to the accumulation of the reporter protein, promoted from an 
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Fig. 3. HBsAg reporter assay (see Materials and methods) with R7-57 cells after chemical 
induction or superinfection (a) and specific trans-activation (b). Expression of the HBsAg 
reporter sequence was measured by radioimmunoassay 2, 4 and 6 days after test start 
(absolute values in cpm x 1000). R7-57 cells were cultivated either untreated or induced 
with the agents indicated (TPA 40nM, butyric acid 3 mM). Superinfection of 10 7 R59Z 
cells with P3HR-1 and B 95-8 virus, prepared from the supernatant of 108 chemically induced 
producer cells, was performed for 1 h at room temperature under gentle movement. Trans- 
fections were done with 10 gg of DNA per 10 7 cells according to the DEAE dextran protocol 
[22, 24]. Transient expression vectors for BZLF 1, BI'LF4 (pCMVZ, pSCI') [23] and 
BRLF 1 (pKSVR) [20] were applied in equimolar concentrations. One third of each 10 ml 
culture volume was taken every two days as an aliquot for assay. Values represent one 
experiment out of three reproductions 
active ori Lyt element. Butyric a id was noted to increase the stimulation by 
TPA. Superinfection of R7-57 cells with EBV preparations resulted likewise in 
lytic signals. Strain-specific differences (P3HR-1, B 95-8) were quantified for 
the level of viral reactivation. In a transfection experiment using transient 
expression vectors encoding single EBV trans-activators, pecific lytic effects 
became vident (trans-activators BZLF 1, BRLF 1, and BI'LF 4, i.e., left frame 
gene products of the EBV genome fragments Barn HI Z, R, and I'). The main 
EBV trans-activator BZLF 1 [5] gave rise to a strong lytic response. In contrast 
to this, the BRLF 1 product, known to activate transcriptional e ements of the 
EBV early regulatory level [7, 13] reacted comparably low. The quantitative 
differences between these two viral proteins indicate the experimental discrim- 
ination between a direct, low-level trans-activator of ori Lyt (BRLF 1) and the 
full lyric transition by a latency breaking ene (BZLF t). Furthermore, xpres- 
sion of BI 'LF 4, described as an additional, specialized regulator of EBV genes 
[23] did not lead to a measurable lytic effect in this cell system. 
The possibility of trans-cellular activation of the lytic cycle was assayed in 
a cocultivation experiment (Fig. 4). R59Z cells were used as activator line, 
directed towards the reporter line R7-57. Separate cultivation of either of the 
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Fig. 4. HBsAg reporter assay with R7-57 and R59Z cells in coculture. Expression of the 
HBsAg reporter sequence was measured by enzyme-linked immunoassay 2, 4 and 6 days 
after test start (absolute values OD492). The cells were cultured separately or in coculture 
at an initial cell density of 107 per 10ml medium. Transfections were done with 10gg of 
DNA per 10 7 cells according to the DEAE dextran protocol [22, 24]. R59Z cell lysates 
were produced by sonication and were incubated ina 5 fold excess (lysate of 5 x 107 R59Z 
cells per 107 R7-57 cells). 107 R59Z cells were superinfected with virus, prepared from the 
supernatant of 108 P3HR-I producer cells, for 1 h at room temperature under gentle 
movement. Virus preparations were inactivated by exposing to ultraviolet light at 302 nm, 
180W at a distance of 5cm for t0min. One third of each 10ml culture supernatant was 
taken every two days as an aliquot for assay. Values represent one experiment out of three 
reproductions 
two cell types did not show reporter effects. As a control, both relevant plasmids 
were introduced into one cell, leading to the BZLF 1 response as described 
above. Incubation of BZLF 1-containing cell lysates did not influence the R7- 
57 reporter line, nor did recombinant BZLF 1 protein, produced in E. coli in 
abundance (not shown). In the same way, no lytic effect was measured by direct 
cocultivation of R59Z with R7-57 cells. The latent stabilization was not broken 
before R59Z cells were superinfected with lytic P3HR-1 virus prior to cocul- 
tivation. In this case, clear lytic activation was transferred from cell to cell, 
presumably resulting from the second round of infection by free virus. Sub- 
sequent inactivation of the superinfecting virus by irradiation largely eliminated 
the trans-cellular effect, thereby confirming this concept. 
Discussion 
The switch between latency and reproduction is a common strategy used by 
various viruses and points out the close adaptation of viral gene regulation to 
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its specific host cell [12]. In the case of Epstein-Barr virus the elements deter- 
mining the latent or lytic course of infection (EBNA-1/ori P or BZLF 1/ori Lyt, 
respectively) have been characterized and interpreted [25]. For analyzing the 
sequence of events in the infected cell, we established recombinant lymphocytes 
imitating specific steps of the lytic cycle. Introducing the ori Lyt element into 
a stable reporter construct we demonstrated an inducible lytic system which 
was strictly repressed under latent conditions. Coordinated lytic transition of 
R7-57 reporter cells was induced experimentally in various ways, e.g., incubation 
with chemical inducers, superinfection with lytic EBV or transient transfection 
with BZLF 1. Our test system, in essence, combines direct trans-activation of 
the recombinant oriLyt element and amplification due to early EBV gene 
products activated from the intact part of the Raji genome. 
Previous contradictory results prompted us to analyze the hypothetical, 
trans-cellular activity of BZLF 1, possibly directed towards the viral genome 
or the cell regulation: Replicative activation of EBV by BZLF 1 was demon- 
strated to be independent from further viral proteins of the lytic cycle [5]. The 
question remained whether BZLF 1 protein could, beyond that, cause cellular 
changes. Such assumptions seemed possible ither directly via BZLF 1 protein, 
shed from destroyed cells as a consequence of a productive cycle of virus 
replication, or alternatively via induction of secreted, cellular factors. In epi- 
thelial cells of oral hairy leukoplakia, bundant typically cytoplasmic expression 
of BZLF 1 was detected in undifferentiated layers [2, 33]. Remarkably, trans- 
regulatory effects which normally lead to the synthesis of succeeding lytic cas- 
cade proteins did not occur in these cells. On the other hand, morphological 
alteration of attached, EBV-negative cells (unpubl. results) were described as 
koilocytic lesions [19]. Furthermore in analogy to retroviral, replicative trans- 
activators, cell to cell-mediated effects of BZLF 1 seemed to be possible. Tat 
protein of HIV-1 was reported to regulate the HIV LTR promoter on the one 
hand and to interfere with cellular growth regulation on the other hand in 
trans-cellular route [8, 14-1. Extracellular Tax1 of HTLV- 1 was shown to regulate 
the expression of endogenous cellular genes [ 18]. 
We therefore constitutively expressed the latency breaking gene of EBV, 
BZLF 1, in R59Z activator cells in a trans-active and noncytotoxic form. Our 
experiments demonstrate hat carefully directed cocultivation of BZLF 1-ex- 
pressing cells with reporter cells did not induce lytic EBV expression. Neither 
BZLF 1 itself nor BZLF 1-induced gene products of the resident Raji genome 
affected viral latency in cocultured cells. Cell-free BZLF 1 protein did likewise 
not influence the endogenous EBV genome and neither were changes detected 
in the cellular growth behaviour or morphology. In contrast to this, lytic tran- 
sition of reporter cells was induced from cell to cell when superinfected activator 
cells were added. This effect was shown to be dependent on complete virus 
replication and release of lytic particles because inactivation ofthe superinfecting 
virus did significantly reduce the reporter signal of the cocultivated cells. 
Our observations state (/) that the dimension of lytic EBV production can 
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directly be correlated to ori Lyt activity, (i0 that ori Lyt activity depends on the 
induction of cellular pathways and on defined viral trans-activators and (iii) 
that BZLF 1 is an efficient intracellular activator, but does not influence co- 
cultured tymphocytes. This does not exclude the possibility of participation of 
BZLF 1 in cellular gene regulation and specific effects in non- lymphoid host 
cell types. Regulatory consequences of abundant and exclusive BZLF 1 pro- 
duction in epithelial tissues, i.e., the presumed correlation to koilocytosis for- 
mation, have to be studied further. 
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